Skip to content

Leuprolide clinical trials: 162 trials

Page 1 of 4

Read 162 Leuprolide clinical trials with posted results or linked papers with results in PepBank.

  1. Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC

    NCT02941926 · Phase 3 · Completed

    Posted results

  2. Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

    NCT00002597 · Phase 3 · Completed

    Posted results

  3. S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

    NCT01674140 · Phase 3 · Active, not recruiting

    Posted results

  4. Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

    NCT00567580 · Phase 3 · Status unknown

    Posted results

  5. Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

    NCT00005044 · Phase 3 · Completed

    Posted results

  6. Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

    NCT00936390 · Phase 3 · Completed

    Posted results

  7. A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

    NCT03085095 · Phase 3 · Completed

    Posted results

  8. Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

    NCT02319837 · Phase 3 · Active, not recruiting

    Posted results

  9. Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer

    NCT00430183 · Phase 3 · Active, not recruiting

    Posted results

  10. The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer

    NCT00295750 · Phase 3 · Completed

    Posted results

  11. A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease

    NCT02663908 · Phase 3 · Terminated

    Posted results

  12. A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)

    NCT00514917 · Phase 3 · Terminated

    Posted results

  13. A Study of Degarelix in Patients With Prostate Cancer

    NCT00928434 · Phase 3 · Completed

    Posted results

  14. Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate

    NCT05605964 · Phase 3 · Completed

    Posted results

  15. A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy

    NCT00451958 · Phase 3 · Completed

    Posted results

  16. A Study of Leuprolide to Treat Prostate Cancer

    NCT00626431 · Phase 3 · Completed

    Posted results

  17. A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants

    NCT02427958 · Phase 4 · Completed

    Posted results

  18. PGL4001 Versus GnRH-agonist in Uterine Myomas

    NCT00740831 · Phase 3 · Completed

    Posted results

  19. A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids

    NCT02655237 · Phase 3 · Completed

    Posted results

  20. Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

    NCT01546987 · Phase 3 · Completed

    Posted results

  21. Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy

    NCT00283062 · Phase 3 · Completed

    Posted results

  22. Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer

    NCT01415960 · Phase 3 · Completed

    Posted results

  23. Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer

    NCT00004635 · Phase 3 · Completed

    Posted results

  24. Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer

    NCT03261999 · Phase 3 · Completed

    Posted results

  25. Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

    NCT02234115 · Phase 3 · Completed

    Posted results

  26. Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

    NCT01161563 · Phase 4 · Completed

    Posted results

  27. A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer

    NCT02085252 · Phase 3 · Completed

    Posted results

  28. Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)

    NCT00805935 · Phase 4 · Completed

    Posted results

  29. A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients

    NCT03035032 · Phase 4 · Completed

    Posted results

  30. Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature

    NCT00355030 · Phase 3 · Completed

    Posted results

  31. A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

    NCT00635817 · Phase 3 · Completed

    Posted results

  32. A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty

    NCT05341115 · Phase 4 · Completed

    Posted results

  33. Prevention of Obesity in Women Via Estradiol Regulation

    NCT00687739 · Phase 3 · Completed

    Posted results

  34. Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

    NCT00667446 · Phase 3 · Completed

    Posted results

  35. Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty

    NCT02452931 · Phase 3 · Completed

    Posted results

  36. Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

    NCT00003645 · Phase 3 · Terminated

    Posted results

  37. Study of Lupron Depot In The Treatment of Central Precocious Puberty

    NCT00660010 · Phase 3 · Completed

    Posted results

  38. A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)

    NCT03695237 · Phase 3 · Completed

    Posted results

  39. Evaluate Recovery of Testosterone for Patients Using Eligard

    NCT01136226 · Phase 4 · Completed

    Posted results

  40. Menopausal Sleep Fragmentation and Body Fat Gain

    NCT03047330 · Phase 4 · Completed

    Posted results

  41. External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

    NCT00388804 · Phase 3 · Terminated

    Posted results

  42. Polycystic Ovary Syndrome (PCOS) and Sleep Apnea

    NCT00203996 · Phase 4 · Terminated

    Posted results

  43. Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

    NCT00621179 · Phase 4 · Completed

    Posted results

  44. Impact of Hot Flashes on Sleep and Mood Disturbance

    NCT01116401 · Phase 4 · Completed

    Posted results

  45. Study of Dual Trigger Ovulation in Oocyte Donors

    NCT01443546 · Phase 4 · Terminated

    Posted results

  46. Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study

    NCT01921166 · Phase 4 · Completed

    Posted results

  47. Understanding Experimentally Induced Hot Flushes

    NCT00455689 · Phase 4 · Completed

    Posted results

  48. GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases

    NCT01257802 · Phase 3 · Terminated

    Posted results

  49. Contributions to Hypertension With Androgen Deprivation Therapy

    NCT05700903 · Phase 4 · Terminated

    Posted results

  50. Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

    NCT01606709 · Phase 4 · Terminated

    Posted results

How PepBank reports evidence